GOLM1 and hepatocellular carcinoma: In several clinical settings, GP73 was shown to be upregulated in a variety of liver diseases, including alcohol-induced liver disease, virus-induced hepatitis (e.g., hepatitis B and C), autoimmune hepatitis, liver cirrhosis, and hepatocellular carcinoma cells (HCC)18–20.